Condensed Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Current assets
Cash	$ 5,822,367	$ 6,989,424
Acquired patents, net	2,682	5,391
Total assets	5,825,049	6,994,815
Current liabilities
Accounts payable & accrued interest	774,759	256,317
Unreimbursed expenses	67,625	38,089
Total current liabilities	842,384	294,406
Total liabilities	842,384	294,406
Stockholders’ equity
Common stock, $0.001 par value; 100,000,000 shares authorized; 13,144,653 and 12,848,165 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively	13,145	12,848
Additional paid-in capital	63,082,679	57,052,130
Accumulated deficit	(58,113,159)	(50,364,569)
Total stockholders’ equity	4,982,665	6,700,409
Total liabilities and stockholders’ equity	$ 5,825,049	$ 6,994,815